Amgen (AMGN) Rises As Market Takes a Dip: Key Facts

Amgen (AMGN) concluded the recent trading session at $371.47, signifying a +1.48% move from its prior day's close.

Zacks Investment Research • 14 hours ago

Amgen settles shareholder lawsuit claiming it hid $10.7 billion tax bill

Amgen reached a $74 million settlement of a lawsuit accusing the biotechnology company of ​waiting too long to disclose that it might owe ‌the Internal Revenue Service $10.7 billion for underreporting six years of taxes.

Reuters • Jul 21, 2026

The First Oral Cholesterol Pill Is Here. Which of These 5 Stocks Benefits Most?

The FDA's approval of Merck (NYSE:MRK | MRK Price Prediction) enlicitide decanoate, marketed as Lipfendra, marks the first once-daily oral PCSK9 inhibitor cleared for adults with high LDL cholesterol, including heterozygous familial hypercholesterolemia.

24/7 Wall Street • Jul 17, 2026

Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?

Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Investment Research • Jul 16, 2026

Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know

Amgen (AMGN) closed the most recent trading day at $355.25, moving 1.44% from the previous trading session.

Zacks Investment Research • Jul 14, 2026

Pfizer Vs. Amgen: Bet That Pfizer's Seagen Integration Leads to Long-Term Oncology Alpha Over Amgen

Pfizer (NYSE: PFE | PFE Price Prediction) and Amgen (NASDAQ: AMGN) both reported Q1 2026 results this quarter, and the numbers reveal two very different bets on the future of oncology.

24/7 Wall Street • Jul 14, 2026

HRMY vs. AMGN: Which Stock Is the Better Value Option?

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Harmony Biosciences Holdings, Inc. (HRMY) and Amgen (AMGN). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research • Jul 14, 2026

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks Investment Research • Jul 13, 2026

Jim Cramer Says Biotech is The Hottest Group in The Market Right Now

CNBC's Jim Cramer pushed viewers away from the usual semiconductor and hyperscaler chatter.

24/7 Wall Street • Jul 9, 2026

How Safe Is Amgen's Dividend?

Amgen is facing several legal and regulatory issues. However, the company's underlying business remains solid.

The Motley Fool • Jul 7, 2026